← Return to How much value to put on the numbers in the Decipher Grid?

Discussion
Comment receiving replies
Profile picture for edwardbrown1 @edwardbrown1

I really appreciate this line of discussion, especially comments by @handera. With a Decipher score of 0.92 putting me in the 98 percentile for risk, so making me very anxious. I have tried to engage my oncologists and even a distinguished research professor at Johns Hopkins Medicine. None could provider any insights. Understandably, the mountain of molecular biology information provided by Vercyte in the Decipher GRID report is way, way beyond the routine standard of care for prostate cancer. Being a PhD biochemist, I have tried myself to learn more about the aberrant genes in my prostate specimens. Of the 60 genes/ expression signatures listed in my GRID report, 19 are listed as of high risk. However, I have to continually remind myself that these results are all only statistical associations. The analyses are not correlations, much less suggesting any insights on differential responses toward therapy and outcomes. Fortunately, my RT and ADT have driven my PSA to undetectable, which has helped my anxiety.
Can any of you suggest clinical researchers anywhere who are engaged with Veracyte to more deeply understand their data? I would really appreciate any recommendations. Thanks again.

Jump to this post


Replies to "I really appreciate this line of discussion, especially comments by @handera. With a Decipher score of..."

@edwardbrown1

Using SuperGrok I found the following research physicians you may want to investigate regarding your questions.

- Dr. Ashley Ross, MD, PhD (Urologic Oncologist, Associate Professor of Urology at Northwestern Medicine)

- Dr. Alan Dal Pra, MD (Director of Clinical Research, Associate Professor of Radiation Oncology at University of Miami Miller School of Medicine)

- Dr. Shuang Zhao, MD (University of Wisconsin-Madison)

- Dr. Emily Grist, PhD (University College London Cancer Institute)

- Dr. Elai Davicioni, PhD (Medical Director for Urology at Veracyte)

- Duke University Team, Including Dr. Edward Schaeffer)

Sorry to hear your Decipher Score was so high.

If you’re interested in a contrarian view (especially since you’re a PhD biochemist) get a copy of “Cancer as a Metabolic Disease - On the Origin, Management, and Prevention of Cancer”, by Thomas N. Seyfried, PhD.

Seyfried is biochemical geneticist who has studied the lipid biochemistry of cancer for 40+ years. His book reads like a biochemistry textbook on steroids, so it’s not for those unfamiliar with biochemistry.